TruBridge, Inc. (NASDAQ:TBRG – Get Free Report) insider Michael Daughton bought 17,500 shares of TruBridge stock in a transaction on Monday, November 17th. The stock was acquired at an average cost of $20.46 per share, with a total value of $358,050.00. Following the acquisition, the insider owned 57,492 shares of the company’s stock, valued at $1,176,286.32. This trade represents a 43.76% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Michael Daughton also recently made the following trade(s):
- On Friday, November 14th, Michael Daughton purchased 2,500 shares of TruBridge stock. The shares were bought at an average cost of $20.15 per share, for a total transaction of $50,375.00.
- On Thursday, November 13th, Michael Daughton purchased 4,354 shares of TruBridge stock. The stock was bought at an average price of $20.16 per share, with a total value of $87,776.64.
- On Wednesday, November 12th, Michael Daughton acquired 10,167 shares of TruBridge stock. The stock was bought at an average price of $19.95 per share, with a total value of $202,831.65.
- On Tuesday, November 11th, Michael Daughton acquired 15,479 shares of TruBridge stock. The shares were bought at an average cost of $19.39 per share, for a total transaction of $300,137.81.
TruBridge Trading Down 2.4%
Shares of TBRG opened at $20.61 on Thursday. TruBridge, Inc. has a twelve month low of $15.69 and a twelve month high of $32.00. The company has a current ratio of 1.80, a quick ratio of 1.79 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $309.34 million, a P/E ratio of -24.54 and a beta of 0.57. The firm’s 50-day moving average is $20.15 and its two-hundred day moving average is $21.60.
Analyst Upgrades and Downgrades
TBRG has been the subject of a number of research analyst reports. BMO Capital Markets started coverage on TruBridge in a research report on Thursday, November 13th. They issued a “market perform” rating and a $19.50 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of TruBridge in a report on Friday, October 31st. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, TruBridge has an average rating of “Hold” and a consensus price target of $25.50.
Read Our Latest Report on TBRG
Institutional Trading of TruBridge
Large investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. raised its holdings in TruBridge by 31.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 152,668 shares of the company’s stock valued at $4,201,000 after acquiring an additional 36,838 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new position in TruBridge in the first quarter valued at $1,415,000. Trexquant Investment LP lifted its position in TruBridge by 221.9% during the first quarter. Trexquant Investment LP now owns 53,944 shares of the company’s stock worth $1,485,000 after buying an additional 37,184 shares during the period. Cubist Systematic Strategies LLC boosted its stake in TruBridge by 106.5% in the 1st quarter. Cubist Systematic Strategies LLC now owns 54,109 shares of the company’s stock worth $1,489,000 after buying an additional 27,907 shares during the last quarter. Finally, Acadian Asset Management LLC grew its holdings in TruBridge by 89.9% in the 2nd quarter. Acadian Asset Management LLC now owns 253,665 shares of the company’s stock valued at $5,937,000 after buying an additional 120,106 shares during the period. Institutional investors and hedge funds own 88.64% of the company’s stock.
About TruBridge
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Further Reading
- Five stocks we like better than TruBridge
- Investing in Commodities: What Are They? How to Invest in Them
- onsemi Places a $6 Billion Bet on Its Own Stock
- How to Read Stock Charts for Beginners
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Consumer Discretionary Stocks Explained
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.
